MedTrace Logo

Game Changers for Cervical Cancer Prevention

NCT06010160 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1400

Last updated 2026-03-20

No results posted yet for this study

Summary

This randomized controlled trial will evaluate Game Changers for Cervical Cancer Prevention (GC-CCP) for increasing cervical cancer (CC) screening advocacy among intervention recipients (index participants) towards female social network members, and uptake of CC screening among enrolled female social network members (alter participants) who have not previously been screened. The main research questions are:

1. Is the GC-CCP network-based peer advocacy intervention superior to usual care (no intervention) in improving uptake of CC screening among alter participants, across urban/rural and public/private clinics?
2. What are the mediators and moderators (among index, alter and network characteristics) of intervention effects on (a) alter CC screening; and (b) engagement in CC prevention advocacy among index participants?

Conditions

Interventions

BEHAVIORAL

Game Changers for Cervical Cancer Prevention

The peer advocacy training sessions focus on reduction of internalized stigma, disclosure decision making, education on cervical cancer facts and myths, and building skills for cervical cancer prevention advocacy.

Sponsors & Collaborators

  • Makerere University

    collaborator OTHER

  • African Palliative Care Association

    collaborator UNKNOWN

  • Rays of Hope Hospice Jinja

    collaborator UNKNOWN

  • Indiana University, Bloomington

    collaborator UNKNOWN

  • RAND

    lead OTHER

Principal Investigators

  • Glenn Wagner, PhD · RAND

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-19
Primary Completion
2026-03-30
Completion
2026-03-30

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06010160 on ClinicalTrials.gov